Tag #Vaccine Sales

Showing 1 to 2 of 2 results

forbes.com
🌐 75% Global Worthiness
News related image

Moderna Stock Plummets 80% on Reduced COVID-19 Vaccine Sales

Moderna's stock price has fallen over 80% in the last year due to an 83% decrease in revenue from its COVID-19 vaccine, dropping from $18.9 billion in 2022 to $3.1 billion over the last twelve months, and projected to reach $2.1 billion in 2025; this is primarily because of reduced demand as the pan...

Progress

56% Bias Score

Good Health and Well-being
nos.nl
🌐 75% Global Worthiness
News related image

Pfizer's Dutch Subsidiary Reports $11.4 Billion Profit Amidst Reduced COVID-19 Vaccine Sales

Pfizer's Dutch subsidiary reported an $11.4 billion profit for the fiscal year ending November 2023, down from previous years due to reduced COVID-19 vaccine and medication sales, but comparable to pre-pandemic levels; the company's revenue decreased from $74.4 billion in 2022 to $46.9 billion in 20...

Progress

40% Bias Score

Good Health and Well-being

Showing 1 to 2 of 2 results